Venture Capital

Ana Therapeutics Announces U.s. Fda Clearance Of Ind Application To Initiate Clinical Trial Of Niclosamide In Covid-19 Patients

by posted 12months ago 276 views
FOSTER CITY, Calif., Aug. 4, 2020 /PRNewswire/ -- ANA Therapeutics (ANA), a Silicon Valley-based biotech start-up announced today that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for ANA001 (niclosamide capsules) as a potential...

In this article